Jean‐Michel Lavoie

Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes

Erin Pleasance, Emma Titmuss, Laura Williamson et al. · Nature Cancer · 2020 · 173 citations

Medicine, Cancer Biology, Oncology +16

Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

Gillian Vandekerkhove, Jean‐Michel Lavoie, Matti Annala et al. · Nature Communications · 2021 · 159 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum

Lucia Nappi, Marisa Thi, Amy Lum et al. · Journal of Clinical Oncology · 2019 · 125 citations · Full text

Medicine, Cancer Biology, Oncology +17

Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer

Nicolette M. Fonseca, Corinne Maurice‐Dror, Cameron Herberts et al. · Nature Communications · 2024 · 120 citations · Full text

Medicine, Biostatistics, Oncology +17

Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Alexandra Pender, Emma Titmuss, Erin Pleasance et al. · Clinical Cancer Research · 2020 · 93 citations · Full text

Medicine, Cancer Biology, Oncology +17